Literature DB >> 27485932

Transformation by different oncogenes relies on specific metabolic adaptations.

Paolo Peruzzo1, Marina Comelli1, Eros Di Giorgio1, Elisa Franforte1, Irene Mavelli1, Claudio Brancolini1.   

Abstract

Metabolic adaptations are emerging as common traits of cancer cells and tumor progression. In vitro transformation of NIH 3T3 cells allows the analysis of the metabolic changes triggered by a single oncogene. In this work, we have compared the metabolic changes induced by H-RAS and by the nuclear resident mutant of histone deacetylase 4 (HDAC4). RAS-transformed cells exhibit a dominant aerobic glycolytic phenotype characterized by up-regulation of glycolytic enzymes, reduced oxygen consumption and a defect in complex I activity. In this model of transformation, glycolysis is strictly required for sustaining the ATP levels and the robust cellular proliferation. By contrast, in HDAC4/TM transformed cells, glycolysis is only modestly up-regulated, lactate secretion is not augmented and, instead, mitochondrial oxygen consumption is increased. Our results demonstrate that cellular transformation can be accomplished through different metabolic adaptations and HDAC4/TM cells can represent a useful model to investigate oncogene-driven metabolic changes besides the Warburg effect.

Entities:  

Keywords:  CLN3; CPT1A; ENO2; GLA; Glycolysis; HDAC4; HDAC5; HDAC7; HDAC9; HK2; MEF2A; MEF2B; MEF2C; MEF2D; NSDHL; OXPHOS; PGK1; PKM2; RHOB; Warburg; class IIa; mitochondria

Mesh:

Substances:

Year:  2016        PMID: 27485932      PMCID: PMC5053564          DOI: 10.1080/15384101.2016.1215387

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  56 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Metabolic Dependencies in RAS-Driven Cancers.

Authors:  Alec C Kimmelman
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

3.  Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements.

Authors:  Arvind Ramanathan; Connie Wang; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-19       Impact factor: 11.205

4.  The control operated by the cell cycle machinery on MEF2 stability contributes to the downregulation of CDKN1A and entry into S phase.

Authors:  Eros Di Giorgio; Enrico Gagliostro; Andrea Clocchiatti; Claudio Brancolini
Journal:  Mol Cell Biol       Date:  2015-03-02       Impact factor: 4.272

5.  Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines.

Authors:  Luigi Fiume; Marcella Manerba; Marina Vettraino; Giuseppina Di Stefano
Journal:  Pharmacology       Date:  2010-08-10       Impact factor: 2.547

6.  The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.

Authors:  Frédéric Dayan; Danièle Roux; M Christiane Brahimi-Horn; Jacques Pouyssegur; Nathalie M Mazure
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

7.  Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER⁺ breast tumors.

Authors:  Andrea Clocchiatti; Eros Di Giorgio; Sabrina Ingrao; Franz-Josef Meyer-Almes; Claudio Tripodo; Claudio Brancolini
Journal:  FASEB J       Date:  2012-11-16       Impact factor: 5.191

8.  GSEA-P: a desktop application for Gene Set Enrichment Analysis.

Authors:  Aravind Subramanian; Heidi Kuehn; Joshua Gould; Pablo Tamayo; Jill P Mesirov
Journal:  Bioinformatics       Date:  2007-07-20       Impact factor: 6.937

Review 9.  Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis.

Authors:  Andrea Clocchiatti; Cristina Florean; Claudio Brancolini
Journal:  J Cell Mol Med       Date:  2011-09       Impact factor: 5.310

10.  Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities.

Authors:  Emma M Kerr; Edoardo Gaude; Frances K Turrell; Christian Frezza; Carla P Martins
Journal:  Nature       Date:  2016-02-24       Impact factor: 49.962

View more
  7 in total

1.  HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers.

Authors:  Eros Di Giorgio; Harikrishnareddy Paluvai; Emiliano Dalla; Liliana Ranzino; Alessandra Renzini; Viviana Moresi; Martina Minisini; Raffaella Picco; Claudio Brancolini
Journal:  Genome Biol       Date:  2021-05-10       Impact factor: 13.583

2.  The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness.

Authors:  Eros Di Giorgio; Elisa Franforte; Sebastiano Cefalù; Sabrina Rossi; Angelo Paolo Dei Tos; Monica Brenca; Maurizio Polano; Roberta Maestro; Harikrishnareddy Paluvai; Raffaella Picco; Claudio Brancolini
Journal:  PLoS Genet       Date:  2017-04-18       Impact factor: 5.917

3.  Unscheduled HDAC4 repressive activity in human fibroblasts triggers TP53-dependent senescence and favors cell transformation.

Authors:  Harikrishnareddy Paluvai; Eros Di Giorgio; Claudio Brancolini
Journal:  Mol Oncol       Date:  2018-11-14       Impact factor: 6.603

Review 4.  Transcriptional Regulation of Energy Metabolism in Cancer Cells.

Authors:  Sara Rodríguez-Enríquez; Álvaro Marín-Hernández; Juan Carlos Gallardo-Pérez; Silvia Cecilia Pacheco-Velázquez; Javier Alejandro Belmont-Díaz; Diana Xochiquetzal Robledo-Cadena; Jorge Luis Vargas-Navarro; Norma Angélica Corona de la Peña; Emma Saavedra; Rafael Moreno-Sánchez
Journal:  Cells       Date:  2019-10-09       Impact factor: 6.600

5.  Genetic Programs Driving Oncogenic Transformation: Lessons from in Vitro Models.

Authors:  Eros Di Giorgio; Harikrishnareddy Paluvai; Raffaella Picco; Claudio Brancolini
Journal:  Int J Mol Sci       Date:  2019-12-12       Impact factor: 5.923

6.  Circular RNA hsa_circRNA_002178 silencing retards breast cancer progression via microRNA-328-3p-mediated inhibition of COL1A1.

Authors:  Ting Liu; Ping Ye; Yuanyuan Ye; Sen Lu; Baosan Han
Journal:  J Cell Mol Med       Date:  2020-01-19       Impact factor: 5.310

Review 7.  The Histone Code of Senescence.

Authors:  Harikrishnareddy Paluvai; Eros Di Giorgio; Claudio Brancolini
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.